Details for: APO-LEVETIRACETAM
Company: APOTEX INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02285924 | APO-LEVETIRACETAM | LEVETIRACETAM | 250 MG | TABLET | ORAL |
| 02285932 | APO-LEVETIRACETAM | LEVETIRACETAM | 500 MG | TABLET | ORAL |
| 02285940 | APO-LEVETIRACETAM | LEVETIRACETAM | 750 MG | TABLET | ORAL |
Summary Reports
Summary Safety Review - KEPPRA (levetiracetam) - Assessing the Potential Risk of Acute Kidney Injury (Acute renal failure/Interstitial nephritis)
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.